Objectives: To report the clinical presentation and outcomes of the APS in Hong Kong
Chinese patients. Methods: The HKAPS registry was established in early 2020 by the Hong …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a
combination of arterial or venous thrombosis and recurrent fetal loss accompanied by …

Early diagnosis of inflammatory joint and connective tissue diseases is key to achieving
effective treatment and improved prognosis. Notably, it also impacts in a patient's quality of …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder in which the patient's
immune system makes antibodies that target their own body cells. These antibodies, known …

Background Antiphospholipid syndrome (APS) is an autoimmune response characterized
clinically by arterial or venous thrombosis. One of the rare and series forms of APS is the …

The antiphospholipid syndrome (APS) is defined by venous or arterial thrombosis and/or
pregnancy morbidity in patients with persistent presence of antiphospholipid antibodies …

Catastrophic antiphospholipid syndrome (CAPS) is a rare condition characterized by
multiple thromboses affecting mainly small vessels in a short period of time in patients with …

In this issue of The Journal, Giron-Gonzalez and colleagues present new information about
the natural history and management of patients with antiphospholipid antibodies (aPL) 1. In …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, namely, lupus anticoagulant (LA), anticardiolipin antibodies …

Discussion Antiphospholipid syndrome is characterized by the presence of autoantibodies
that bind cell membrane phospholipids or phospholipid-binding proteins and by evidence of …